Insiders · CUE

CUE insider transactions

Cue Biopharma Inc. (CUE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CUE

• 1d
  SEC Form 4 filed by Director Camardo Daniel A.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1d
  SEC Form 3 filed by new insider Camardo Daniel A.

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 6d
  SEC Form 4 filed by Chief Executive Officer Lin Shao-Lee

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 6d
  SEC Form 4 filed by Director Meehan Viola Mong

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 6d
  SEC Form 3 filed by new insider Meehan Viola Mong

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 33d
  SEC Form 3 filed by new insider Lin Shao-Lee

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 33d
  CHIEF EXECUTIVE OFFICER Lin Shao-Lee was granted 327,537 shares (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 60d
  SEC Form 4 filed by Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 60d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 60d
  SEC Form 4 filed by Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 154d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 158d
  Director Sarraf Pasha bought $99,747 worth of shares (323,857 units at $0.31) (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 185d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 196d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 196d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 249d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Azam Usman

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 249d
  SEC Form 3 filed by new insider Azam Usman

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 368d
  SEC Form 4 filed by Director Broadfoot Jill Marie

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 368d
  SEC Form 3 filed by new insider Broadfoot Jill Marie

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 441d
  SEC Form 4 filed by Chief Medical Officer Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 454d
  SEC Form 3 filed by new insider Sarraf Pasha

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 454d
  SEC Form 4 filed by Director Sarraf Pasha

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 522d
  SEC Form 4 filed by Director Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 522d
  SEC Form 4 filed by Director Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 522d
  SEC Form 4 filed by Director Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 522d
  SEC Form 4 filed by Director Driscoll Frederick W

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 522d
  SEC Form 4 filed by Director Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 538d
  CHIEF EXECUTIVE OFFICER Passeri Daniel R bought $30,900 worth of shares (30,000 units at $1.03), increasing direct ownership by 22% to 164,578 units (SEC Form 4)

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 557d
  SEC Form 3 filed by new insider Baker Daniel G.

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 557d
  SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 642d
  SEC Form 3 filed by new insider Warren Lucinda

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 642d
  SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  SEC Form 4 filed by Fox Michael J

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  New insider Fox Michael J claimed ownership of 1,100,000 shares (SEC Form 3)

  3 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 732d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 823d
  SEC Form 4 filed by Millar Kerri-Ann

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 823d
  SEC Form 4 filed by Suri Anish

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 823d
  SEC Form 4 filed by Sandercock Colin

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 823d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 823d
  SEC Form 4 filed by Passeri Daniel R

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 838d
  SEC Form 4 filed by Levisetti Matteo

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 887d
  SEC Form 4 filed by Garzone Pamela

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 887d
  SEC Form 4 filed by Kiener Peter A

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 887d
  SEC Form 4 filed by Driscoll Frederick W

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 887d
  SEC Form 4 filed by Verheyen Patrick

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 887d
  SEC Form 4 filed by Morich Frank

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)
• 1015d
  SEC Form 4: Suri Anish bought $11,040 worth of shares (4,000 units at $2.76), increasing direct ownership by 3% to 135,638 units

  4 - Cue Biopharma, Inc. (0001645460) (Issuer)